Sabotaging of the oxidative stress response by an oncogenic noncoding RNA

Overexpression of the multiple myeloma set domain (MMSET) Wolf‐Hirschhorn syndrome candidate 1 gene, which contains an orphan box H/ACA class small nucleolar RNA, ACA11, in an intron, is associated with several cancer types, including multiple myeloma (MM). ACA11 and MMSET are overexpressed cotranscriptionally as a result of the t (4;14) chromosomal translocation in a subset of patients with MM. RNA sequencing of CD138+ tumor cells from t (4;14)‐positive and ‐negative MM patient bone marrow samples revealed an enhanced oxidative phosphorylation mRNA signature. Supporting these data, ACA11 overexpression in a t (4;14)‐negative MM cell line, MM1.S, demonstrated enhanced reactive oxygen species (ROS) levels. In addition, an enhancement of cell proliferation, increased soft agar colony size, and elevated ERK1/2 phosphorylation were observed. This ACA11‐driven hyperproliferative phenotype depended on increased ROS levels as exogenously added antioxidants attenuate the increased proliferation. A major transcriptional regulator of the cellular antioxidant response, nuclear factor (erythroid‐derived 2)‐like 2 (NRF2), shuttled to the nucleus, as expected, in response to ACA11‐driven increases in ROS; however, transcriptional up‐regulation of some of NRF2's antioxidant target genes was abrogated in the presence of ACA11 overexpression. These data show for the first time that ACA11 promotes proliferation through inhibition of NRF2 function resulting in sustained ROS levels driving cancer cell proliferation.—Mahajan, N., Wu, H.‐J., Bennett, R.L., Troche, C., Licht, J.D., Weber, J. D., Maggi, L. B., Jr., Tomasson, M. H. Sabotaging of the oxidative stress response by an oncogenic noncoding RNA. FASEB J. 31, 482–490 (2017). www.fasebj.org

[1]  M. Tomasson,et al.  Deletion of Rb1 induces both hyperproliferation and cell death in murine germinal center B cells. , 2016, Experimental hematology.

[2]  J. Puglisi,et al.  The noncoding RNAs SNORD50A and SNORD50B bind K-Ras and are recurrently deleted in human cancer , 2015, Nature Genetics.

[3]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[4]  Lucas B. Sullivan,et al.  Mitochondrial reactive oxygen species and cancer , 2014, Cancer & Metabolism.

[5]  Paul Theodor Pyl,et al.  HTSeq – A Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[6]  B. Rogelj,et al.  The many faces of small nucleolar RNAs. , 2014, Biochimica et biophysica acta.

[7]  N. Chandel,et al.  ROS Function in Redox Signaling and Oxidative Stress , 2014, Current Biology.

[8]  J. Weber,et al.  ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis. , 2014, Cell reports.

[9]  J. Steitz,et al.  The Noncoding RNA Revolution—Trashing Old Rules to Forge New Ones , 2014, Cell.

[10]  I. Thompson,et al.  Elevated snoRNA biogenesis is essential in breast cancer , 2014, Oncogene.

[11]  A. Tonevitsky,et al.  New functions of small nucleolar RNAs , 2013, Biochemistry (Moscow).

[12]  D C Johnson,et al.  MMSET is the key molecular target in t(4;14) myeloma , 2013, Blood Cancer Journal.

[13]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[14]  N. Mahajan,et al.  Tumor-suppressive Maspin Functions as a Reactive Oxygen Species Scavenger , 2013, The Journal of Biological Chemistry.

[15]  S. Crosby,et al.  Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress. , 2012, The Journal of clinical investigation.

[16]  F. Jiang,et al.  Small nucleolar RNAs in cancer. , 2012, Biochimica et biophysica acta.

[17]  M. Sporn,et al.  NRF2 and cancer: the good, the bad and the importance of context , 2012, Nature Reviews Cancer.

[18]  F. Farzaneh,et al.  Are snoRNAs and snoRNA host genes new players in cancer? , 2012, Nature Reviews Cancer.

[19]  A. Kenneth,et al.  Molecular heterogeneity of multiple myeloma: pathogenesis, prognosis, and therapeutic implications. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  L. Staudt,et al.  The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. , 2011, Blood.

[21]  J. Fujii,et al.  B- to plasma-cell terminal differentiation entails oxidative stress and profound reshaping of the antioxidant responses. , 2010, Antioxidants & redox signaling.

[22]  L. Kumar,et al.  Study of antioxidant levels in patients with multiple myeloma , 2009, Leukemia & lymphoma.

[23]  M. Ferrarini,et al.  Redox homeostasis modulates the sensitivity of myeloma cells to bortezomib , 2008, British journal of haematology.

[24]  F. Zhan,et al.  A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript. , 2003, Blood.

[25]  P. L. Bergsagel,et al.  Multiple myeloma: evolving genetic events and host interactions , 2002, Nature Reviews Cancer.

[26]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[27]  N. Holbrook,et al.  The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. , 1998, The Biochemical journal.

[28]  L. Desbarats,et al.  Myc: a single gene controls both proliferation and apoptosis in mammalian cells , 1996, Experientia.

[29]  K. Halprin,et al.  The measurement of glutathione in human epidermis using glutathione reductase. , 1967, The Journal of investigative dermatology.

[30]  P. L. Bergsagel,et al.  The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. , 1998, Blood.

[31]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[32]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .